ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993

NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center.

March 3, 2006

Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA

June 20, 1986

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014